臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"chiun hsu"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 276-300 of 356 (15 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-04-10T12:51:03Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Chiun Hsu;Hsu C.-H.;Tien Y.-W.;Yeh K.-H.;Cheng A.-L.;Kuo S.-H.; Yang S.-H.; Kuo T.-C.; Wu H.; Guo J.-C.; Chiun Hsu; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2020-04-10T12:51:03Z	Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer	Chen L.-T.; Huang S.-F.; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Chiun Hsu; Chiang N.-J.; Chiang N.-J.;Chiun Hsu;Chen J.-S.;Tsou H.-H.;Shen Y.-Y.;Chao Y.;Chen M.-H.;Yeh T.-S.;Shan Y.-S.;Huang S.-F.;Chen L.-T.
臺大學術典藏	2020-04-10T12:51:03Z	Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges	Lu L.-C.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:03Z	Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression	Chiun Hsu; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; Shao Y.-Y.; Cheng A.-L.; Ou D.-L.
臺大學術典藏	2020-04-10T12:51:02Z	Simultaneous visualization of the subfemtomolar expression of microRNA and microRNA target gene using HILO microscopy	Chang P.-L.; Lin W.-Y.; Chiun Hsu; Chang H.-Y.; Ou D.-L.; Lin Y.-Z.; Lin Y.-Z.;Ou D.-L.;Chang H.-Y.;Lin W.-Y.;Chiun Hsu;Chang P.-L.
臺大學術典藏	2020-04-10T12:51:02Z	Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial	Melero I.; Dastani H.B.; Tang H.; Neely J.; El-Khoueiry A.B.;Sangro B.;Yau T.;Crocenzi T.S.;Kudo M.;Chiun Hsu;Kim T.-Y.;Choo S.-P.;Trojan J.;Welling T.H.;3Rd, Meyer T.;Kang Y.-K.;Yeo W.;Chopra A.;Anderson J.;Dela Cruz C.;Lang L.;Neely J.;Tang H.;Dastani H.B.;Melero I.; El-Khoueiry A.B.; Sangro B.; Yau T.; Crocenzi T.S.; Kudo M.; Chiun Hsu; Kim T.-Y.; Choo S.-P.; Trojan J.; Welling T.H.; 3rd, Meyer T.; Kang Y.-K.; Yeo W.; Chopra A.; Anderson J.; dela Cruz C.; Lang L.
臺大學術典藏	2020-04-10T12:51:01Z	Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy	Lin Y.-Y.;Tan C.-T.;Chen C.-W.;Ou D.-L.;Cheng A.-L.;Chiun Hsu; Lin Y.-Y.; Tan C.-T.; Chen C.-W.; Ou D.-L.; Cheng A.-L.; Chiun Hsu
臺大學術典藏	2020-04-10T12:51:01Z	Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYNOTE-028 study	Chiun Hsu;Lee S.-H.;Ejadi S.;Even C.;Cohen R.B.;Le Tourneau C.;Mehnert J.M.;Algazi A.;Van Brummelen E.M.J.;Saraf S.;Thanigaimani P.;Cheng J.D.;Hansen A.R.; Chiun Hsu; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J.; Saraf S.; Thanigaimani P.; Cheng J.D.; Hansen A.R.
臺大學術典藏	2020-04-10T12:51:01Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	Shao Y.-Y.;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Chiun Hsu; Shao Y.-Y.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Chiun Hsu
臺大學術典藏	2020-04-10T12:51:01Z	Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma	Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Chiun Hsu;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Chiun Hsu; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2020-04-10T12:51:00Z	Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma	Ou D.-L.;Lin Y.-Y.;Hsu C.-L.;Lin Y.-Y.;Chen C.-W.;Yu J.-S.;Miaw S.-C.;Hsu P.-N.;Cheng A.-L.;Chiun Hsu; Ou D.-L.; Lin Y.-Y.; Hsu C.-L.; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; Hsu P.-N.; Cheng A.-L.; Chiun Hsu
臺大學術典藏	2020-04-10T12:51:00Z	Comparative safety of immune checkpoint inhibitors in cancer: Systematic review and network meta-analysis	Xu C.;Chen Y.-P.;Du X.-J.;Liu J.-Q.;Huang C.-L.;Chen L.;Zhou G.-Q.;Li W.-F.;Mao Y.-P.;Chiun Hsu;Liu Q.;Lin A.-H.;Tang L.-L.;Sun Y.;Ma J.; Xu C.; Chen Y.-P.; Du X.-J.; Liu J.-Q.; Huang C.-L.; Chen L.; Zhou G.-Q.; Li W.-F.; Mao Y.-P.; Chiun Hsu; Liu Q.; Lin A.-H.; Tang L.-L.; Sun Y.; Ma J.
臺大學術典藏	2020-04-10T12:51:00Z	Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection	Taiwan Cooperative Oncology Group; Chiun Hsu; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; Chen P.-J.; Cheng A.-L.; Tsou H.-H.; Yang H.-C.; Yang H.-C.;Tsou H.-H.;Pei S.-N.;Chang C.-S.;Chen J.-H.;Yao M.;Lin S.-J.;Lin J.;Yuan Q.;Xia N.;Liu T.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group
臺大學術典藏	2020-04-10T12:50:59Z	Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection	Tsou H.-H.;Yang H.-C.;Hsiao C.-F.;Hsiung C.A.;Liu T.-W.;Chuang M.-H.;Wu H.-Y.;Hsu Y.-T.;Tsui C.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group; Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; Cheng A.-L.; Chiun Hsu; Taiwan Cooperative Oncology Group
臺大學術典藏	2020-04-10T12:50:58Z	Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients	Yang S.-H.;Guo J.-C.;Chiun Hsu;Kuo S.-H.;Tien Y.-W.;Cheng A.-L.;Yeh K.-H.; Yang S.-H.; Guo J.-C.; Chiun Hsu; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-04-09T09:32:39Z	Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Chih‐Hung Hsu;Ann‐Lii Cheng;Zhong‐Zhe Lin;Yin‐Chung Shen;Li‐Chun Lu;Chiun Hsu;Tsung‐Hao Liu;Yu‐Yun Shao; Yu‐Yun Shao; Tsung‐Hao Liu; Chiun Hsu; Li‐Chun Lu; Yin‐Chung Shen; Zhong‐Zhe Lin; Ann‐Lii Cheng; Chih‐Hung Hsu
臺大學術典藏	2020-04-07T08:52:19Z	Group Report Contest Enhances Problem-Based Learning	Chiun Hsu; Shan-Chwen Chang; Fen-Yu Tseng; Jeng-Yi Shieh;Chien-An Yao;Chiun Hsu;Shan-Chwen Chang;Fen-Yu Tseng; JENG-YI SHIEH; Chien-An Yao
臺大學術典藏	2020	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Tsou H.-H.; CHIUN HSU; Yen C.-J.; Yang S.-H.; Chen M.-H.; Chiang N.-J.
臺大學術典藏	2020	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study	Shen W.-C.; CHIUN HSU; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Hsiao H.-H.; Yang S.-H.; Tsai K.K.; Hsiao C.-F.; Chiang N.-J.
臺大學術典藏	2020	Efficacy and Safety of Nivolumab plus Ipilimumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib: The CheckMate 040 Randomized Clinical Trial	Yau T.; Kang Y.-K.; Kim T.-Y.; El-Khoueiry A.B.; Santoro A.; Sangro B.; Melero I.; Kudo M.; Hou M.-M.; Matilla A.; Tovoli F.; Knox J.J.; Ruth He A.; El-Rayes B.F.; Acosta-Rivera M.; Lim H.-Y.; Neely J.; Shen Y.; Wisniewski T.; Anderson J.; CHIUN HSU
臺大學術典藏	2020	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy	Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lee R.-C.; Chao Y.; CHIUN HSU
臺大學術典藏	2019	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Lu L.-C.; Shen Y.-C.; Chiun Hsu; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.; Liu T.-H.; Shao Y.-Y.
臺大學術典藏	2019	Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis	Yau T.;Chiun Hsu;Kim T.-Y.;Choo S.-P.;Kang Y.-K.;Hou M.-M.;Numata K.;Yeo W.;Chopra A.;Ikeda M.;Kuromatsu R.;Moriguchi M.;Chao Y.;Zhao H.;Anderson J.;Cruz C.D.;Kudo M.; Yau T.; Chiun Hsu; Kim T.-Y.; Choo S.-P.; Kang Y.-K.; Hou M.-M.; Numata K.; Yeo W.; Chopra A.; Ikeda M.; Kuromatsu R.; Moriguchi M.; Chao Y.; Zhao H.; Anderson J.; Cruz C.D.; Kudo M.
臺大學術典藏	2019	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2019	Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma	Lin Z.-Z.; CHIUN HSU; Jeng Y.-M.; Hu F.-C.; Pan H.-W.; Wu Y.-M.; Hsu H.-C.; Cheng A.-L.

Showing items 276-300 of 356 (15 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2817030
	???header.visitor??? : 27633677 ???header.onlineuser??? : 1399 ???header.sponsordeclaration???